Paper42908035PubMed
Multiomics, multi-species profiling, and animal validation identify mitoxyperilysis as a conserved therapeutic target in metabolic dysfunction-associated steatohepatitis.
Liu H and 8 others. Biol Direct, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Multiomics, multi-species profiling, and animal validation identify mitoxyperilysis as a conserved therapeutic target in metabolic dysfunction-associated steatohepatitis. Papers, record 42908035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42908035
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multiomics, multi-species profiling, and animal validation identify mitoxyperilysis as a conserved therapeutic target in metabolic dysfunction-associated steatohepatitis.
- Journal
- Biol Direct
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-24
Source PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fatty Liver | Major topic |
| Metabolic Diseases | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Multiomics | |
| Male | |
| Transcriptome | |
| Disease Models, Animal |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29,914,354 | Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. | BMC Genomics | 2018 | https://conductscience.org/library/papers/29914354 | PubMed |
| 2 | 31,891,606 | Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH). | PLoS One | 2019 | https://conductscience.org/library/papers/31891606 | PubMed |
| 3 | 38,036,728 | Mitochondrial nucleic acids in innate immunity and beyond. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/38036728 | PubMed |
| 4 | 39,838,105 | Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer. | Nat Immunol | 2025 | https://conductscience.org/library/papers/39838105 | PubMed |
| 5 | 37,939,656 | The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. | Cell Metab | 2023 | https://conductscience.org/library/papers/37939656 | PubMed |
| 6 | 36,052,866 | Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis. | Mol Med Rep | 2022 | https://conductscience.org/library/papers/36052866 | PubMed |
| 7 | 38,908,436 | Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation. | J Hepatol | 2024 | https://conductscience.org/library/papers/38908436 | PubMed |
| 8 | 34,050,922 | Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship. | Eur J Clin Invest | 2022 | https://conductscience.org/library/papers/34050922 | PubMed |
| 9 | 39,244,571 | Targeting cell death in NAFLD: mechanisms and targeted therapies. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/39244571 | PubMed |
| 10 | 37,756,381 | Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/37756381 | PubMed |
| 11 | 41,286,103 | Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease. | Nat Genet | 2025 | https://conductscience.org/library/papers/41286103 | PubMed |
| 12 | 40,568,942 | MEBOCOST maps metabolite-mediated intercellular communications using single-cell RNA-seq. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40568942 | PubMed |
| 13 | 42,088,521 | Integrated transcriptomic and single cell analysis combined with artificial neural network identifies a robust gene signature for early discrimination of MASL and MASH. | Front Immunol | 2026 | https://conductscience.org/library/papers/42088521 | PubMed |
| 14 | 38,438,948 | CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis. | J Hepatol | 2024 | https://conductscience.org/library/papers/38438948 | PubMed |
| 15 | 41,317,732 | Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis. | Cell | 2025 | https://conductscience.org/library/papers/41317732 | PubMed |
| 16 | 35,501,558 | Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. | Curr Obes Rep | 2022 | https://conductscience.org/library/papers/35501558 | PubMed |
| 17 | 41,096,980 | Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096980 | PubMed |
| 18 | 31,974,247 | Single-cell transcriptional diversity is a hallmark of developmental potential. | Science | 2020 | https://conductscience.org/library/papers/31974247 | PubMed |
| 19 | 31,992,752 | Biomarker discovery for chronic liver diseases by multi-omics - a preclinical case study. | Sci Rep | 2020 | https://conductscience.org/library/papers/31992752 | PubMed |
| 20 | 27,942,596 | Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. | JCI Insight | 2016 | https://conductscience.org/library/papers/27942596 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42908035
GET https://conductscience.org/api/papers/v1/42908035/references?page=2